Selected research
Market Analysis & Forecast
Global Patient Scheduling Platform Market Analysis and Forecast 2026-2032
Market perspective
The global Patient Scheduling Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Patient Scheduling Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Patient Scheduling Platform include WellSky Scheduling, AdvancedMD, Weave, Carepatron, DoctorConnect.net, McKesson, WebPT, Yocale and Luma Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Patient Scheduling Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Patient Scheduling Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Patient Scheduling Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Patient Scheduling Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Patient Scheduling Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Patient Scheduling Platform revenue, projected growth trends, production technology, application and end-user industry.
Patient Scheduling Platform Segment by Company
WellSky Scheduling
AdvancedMD
Weave
Carepatron
DoctorConnect.net
McKesson
WebPT
Yocale
Luma Health
Setmore
oicent Communications
Total Recall Solutions
Mediware Information Systems
TimeTrade Systems
Relatient
Skedulo
American Medical Software
Clearwave
Upvio
TIMIFY
Nuesoft Technologies
Patient Scheduling Platform Segment by Type
Cloud-based
On-premise
Patient Scheduling Platform Segment by Application
Hospital
Specialist Clinic
Others
Patient Scheduling Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Patient Scheduling Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Patient Scheduling Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Patient Scheduling Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Patient Scheduling Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Patient Scheduling Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Patient Scheduling Platform revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premise
Applications
- Hospital
- Specialist Clinic
- Others
Companies covered
- WellSky Scheduling
- AdvancedMD
- Weave
- Carepatron
- DoctorConnect.net
- McKesson
- WebPT
- Yocale
- Luma Health
- Setmore
- oicent Communications
- Total Recall Solutions
- Mediware Information Systems
- TimeTrade Systems
- Relatient
- Skedulo
- American Medical Software
- Clearwave
- Upvio
- TIMIFY
- Nuesoft Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Patient Scheduling Platform Market by Type
- 1.2.1 Global Patient Scheduling Platform Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cloud-based
- 1.2.3 On-premise
- 1.3 Patient Scheduling Platform Market by Application
- 1.3.1 Global Patient Scheduling Platform Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Specialist Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Patient Scheduling Platform Market Dynamics
- 2.1 Patient Scheduling Platform Industry Trends
- 2.2 Patient Scheduling Platform Industry Drivers
- 2.3 Patient Scheduling Platform Industry Opportunities and Challenges
- 2.4 Patient Scheduling Platform Industry Restraints
3 Global Growth Perspective
- 3.1 Global Patient Scheduling Platform Market Perspective (2021-2032)
- 3.2 Global Patient Scheduling Platform Growth Trends by Region
- 3.2.1 Global Patient Scheduling Platform Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Patient Scheduling Platform Market Size by Region (2021-2026)
- 3.2.3 Global Patient Scheduling Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Patient Scheduling Platform Revenue by Players
- 4.1.1 Global Patient Scheduling Platform Revenue by Players (2021-2026)
- 4.1.2 Global Patient Scheduling Platform Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Patient Scheduling Platform Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Patient Scheduling Platform Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Patient Scheduling Platform Key Players Headquarters & Area Served
- 4.4 Global Patient Scheduling Platform Players, Product Type & Application
- 4.5 Global Patient Scheduling Platform Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Patient Scheduling Platform Market CR5 and HHI
- 4.6.3 2025 Patient Scheduling Platform Tier 1, Tier 2, and Tier 3
5 Patient Scheduling Platform Market Size by Type
- 5.1 Global Patient Scheduling Platform Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Patient Scheduling Platform Revenue by Type (2021-2032)
- 5.3 Global Patient Scheduling Platform Revenue Market Share by Type (2021-2032)
6 Patient Scheduling Platform Market Size by Application
- 6.1 Global Patient Scheduling Platform Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Patient Scheduling Platform Revenue by Application (2021-2032)
- 6.3 Global Patient Scheduling Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 WellSky Scheduling
- 7.1.1 WellSky Scheduling Company Information
- 7.1.2 WellSky Scheduling Business Overview
- 7.1.3 WellSky Scheduling Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.1.4 WellSky Scheduling Patient Scheduling Platform Product Portfolio
- 7.1.5 WellSky Scheduling Recent Developments
- 7.2 AdvancedMD
- 7.2.1 AdvancedMD Company Information
- 7.2.2 AdvancedMD Business Overview
- 7.2.3 AdvancedMD Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.2.4 AdvancedMD Patient Scheduling Platform Product Portfolio
- 7.2.5 AdvancedMD Recent Developments
- 7.3 Weave
- 7.3.1 Weave Company Information
- 7.3.2 Weave Business Overview
- 7.3.3 Weave Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.3.4 Weave Patient Scheduling Platform Product Portfolio
- 7.3.5 Weave Recent Developments
- 7.4 Carepatron
- 7.4.1 Carepatron Company Information
- 7.4.2 Carepatron Business Overview
- 7.4.3 Carepatron Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.4.4 Carepatron Patient Scheduling Platform Product Portfolio
- 7.4.5 Carepatron Recent Developments
- 7.5 DoctorConnect.net
- 7.5.1 DoctorConnect.net Company Information
- 7.5.2 DoctorConnect.net Business Overview
- 7.5.3 DoctorConnect.net Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.5.4 DoctorConnect.net Patient Scheduling Platform Product Portfolio
- 7.5.5 DoctorConnect.net Recent Developments
- 7.6 McKesson
- 7.6.1 McKesson Company Information
- 7.6.2 McKesson Business Overview
- 7.6.3 McKesson Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.6.4 McKesson Patient Scheduling Platform Product Portfolio
- 7.6.5 McKesson Recent Developments
- 7.7 WebPT
- 7.7.1 WebPT Company Information
- 7.7.2 WebPT Business Overview
- 7.7.3 WebPT Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.7.4 WebPT Patient Scheduling Platform Product Portfolio
- 7.7.5 WebPT Recent Developments
- 7.8 Yocale
- 7.8.1 Yocale Company Information
- 7.8.2 Yocale Business Overview
- 7.8.3 Yocale Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.8.4 Yocale Patient Scheduling Platform Product Portfolio
- 7.8.5 Yocale Recent Developments
- 7.9 Luma Health
- 7.9.1 Luma Health Company Information
- 7.9.2 Luma Health Business Overview
- 7.9.3 Luma Health Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.9.4 Luma Health Patient Scheduling Platform Product Portfolio
- 7.9.5 Luma Health Recent Developments
- 7.10 Setmore
- 7.10.1 Setmore Company Information
- 7.10.2 Setmore Business Overview
- 7.10.3 Setmore Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.10.4 Setmore Patient Scheduling Platform Product Portfolio
- 7.10.5 Setmore Recent Developments
- 7.11 oicent Communications
- 7.11.1 oicent Communications Company Information
- 7.11.2 oicent Communications Business Overview
- 7.11.3 oicent Communications Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.11.4 oicent Communications Patient Scheduling Platform Product Portfolio
- 7.11.5 oicent Communications Recent Developments
- 7.12 Total Recall Solutions
- 7.12.1 Total Recall Solutions Company Information
- 7.12.2 Total Recall Solutions Business Overview
- 7.12.3 Total Recall Solutions Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.12.4 Total Recall Solutions Patient Scheduling Platform Product Portfolio
- 7.12.5 Total Recall Solutions Recent Developments
- 7.13 Mediware Information Systems
- 7.13.1 Mediware Information Systems Company Information
- 7.13.2 Mediware Information Systems Business Overview
- 7.13.3 Mediware Information Systems Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.13.4 Mediware Information Systems Patient Scheduling Platform Product Portfolio
- 7.13.5 Mediware Information Systems Recent Developments
- 7.14 TimeTrade Systems
- 7.14.1 TimeTrade Systems Company Information
- 7.14.2 TimeTrade Systems Business Overview
- 7.14.3 TimeTrade Systems Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.14.4 TimeTrade Systems Patient Scheduling Platform Product Portfolio
- 7.14.5 TimeTrade Systems Recent Developments
- 7.15 Relatient
- 7.15.1 Relatient Company Information
- 7.15.2 Relatient Business Overview
- 7.15.3 Relatient Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.15.4 Relatient Patient Scheduling Platform Product Portfolio
- 7.15.5 Relatient Recent Developments
- 7.16 Skedulo
- 7.16.1 Skedulo Company Information
- 7.16.2 Skedulo Business Overview
- 7.16.3 Skedulo Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.16.4 Skedulo Patient Scheduling Platform Product Portfolio
- 7.16.5 Skedulo Recent Developments
- 7.17 American Medical Software
- 7.17.1 American Medical Software Company Information
- 7.17.2 American Medical Software Business Overview
- 7.17.3 American Medical Software Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.17.4 American Medical Software Patient Scheduling Platform Product Portfolio
- 7.17.5 American Medical Software Recent Developments
- 7.18 Clearwave
- 7.18.1 Clearwave Company Information
- 7.18.2 Clearwave Business Overview
- 7.18.3 Clearwave Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.18.4 Clearwave Patient Scheduling Platform Product Portfolio
- 7.18.5 Clearwave Recent Developments
- 7.19 Upvio
- 7.19.1 Upvio Company Information
- 7.19.2 Upvio Business Overview
- 7.19.3 Upvio Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.19.4 Upvio Patient Scheduling Platform Product Portfolio
- 7.19.5 Upvio Recent Developments
- 7.20 TIMIFY
- 7.20.1 TIMIFY Company Information
- 7.20.2 TIMIFY Business Overview
- 7.20.3 TIMIFY Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.20.4 TIMIFY Patient Scheduling Platform Product Portfolio
- 7.20.5 TIMIFY Recent Developments
- 7.21 Nuesoft Technologies
- 7.21.1 Nuesoft Technologies Company Information
- 7.21.2 Nuesoft Technologies Business Overview
- 7.21.3 Nuesoft Technologies Patient Scheduling Platform Revenue and Gross Margin (2021-2026)
- 7.21.4 Nuesoft Technologies Patient Scheduling Platform Product Portfolio
- 7.21.5 Nuesoft Technologies Recent Developments
8 North America
- 8.1 North America Patient Scheduling Platform Revenue (2021-2032)
- 8.2 North America Patient Scheduling Platform Revenue by Type (2021-2032)
- 8.2.1 North America Patient Scheduling Platform Revenue by Type (2021-2026)
- 8.2.2 North America Patient Scheduling Platform Revenue by Type (2027-2032)
- 8.3 North America Patient Scheduling Platform Revenue Share by Type (2021-2032)
- 8.4 North America Patient Scheduling Platform Revenue by Application (2021-2032)
- 8.4.1 North America Patient Scheduling Platform Revenue by Application (2021-2026)
- 8.4.2 North America Patient Scheduling Platform Revenue by Application (2027-2032)
- 8.5 North America Patient Scheduling Platform Revenue Share by Application (2021-2032)
- 8.6 North America Patient Scheduling Platform Revenue by Country
- 8.6.1 North America Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Patient Scheduling Platform Revenue by Country (2021-2026)
- 8.6.3 North America Patient Scheduling Platform Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Patient Scheduling Platform Revenue (2021-2032)
- 9.2 Europe Patient Scheduling Platform Revenue by Type (2021-2032)
- 9.2.1 Europe Patient Scheduling Platform Revenue by Type (2021-2026)
- 9.2.2 Europe Patient Scheduling Platform Revenue by Type (2027-2032)
- 9.3 Europe Patient Scheduling Platform Revenue Share by Type (2021-2032)
- 9.4 Europe Patient Scheduling Platform Revenue by Application (2021-2032)
- 9.4.1 Europe Patient Scheduling Platform Revenue by Application (2021-2026)
- 9.4.2 Europe Patient Scheduling Platform Revenue by Application (2027-2032)
- 9.5 Europe Patient Scheduling Platform Revenue Share by Application (2021-2032)
- 9.6 Europe Patient Scheduling Platform Revenue by Country
- 9.6.1 Europe Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Patient Scheduling Platform Revenue by Country (2021-2026)
- 9.6.3 Europe Patient Scheduling Platform Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Patient Scheduling Platform Revenue (2021-2032)
- 10.2 China Patient Scheduling Platform Revenue by Type (2021-2032)
- 10.2.1 China Patient Scheduling Platform Revenue by Type (2021-2026)
- 10.2.2 China Patient Scheduling Platform Revenue by Type (2027-2032)
- 10.3 China Patient Scheduling Platform Revenue Share by Type (2021-2032)
- 10.4 China Patient Scheduling Platform Revenue by Application (2021-2032)
- 10.4.1 China Patient Scheduling Platform Revenue by Application (2021-2026)
- 10.4.2 China Patient Scheduling Platform Revenue by Application (2027-2032)
- 10.5 China Patient Scheduling Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Patient Scheduling Platform Revenue (2021-2032)
- 11.2 Asia Patient Scheduling Platform Revenue by Type (2021-2032)
- 11.2.1 Asia Patient Scheduling Platform Revenue by Type (2021-2026)
- 11.2.2 Asia Patient Scheduling Platform Revenue by Type (2027-2032)
- 11.3 Asia Patient Scheduling Platform Revenue Share by Type (2021-2032)
- 11.4 Asia Patient Scheduling Platform Revenue by Application (2021-2032)
- 11.4.1 Asia Patient Scheduling Platform Revenue by Application (2021-2026)
- 11.4.2 Asia Patient Scheduling Platform Revenue by Application (2027-2032)
- 11.5 Asia Patient Scheduling Platform Revenue Share by Application (2021-2032)
- 11.6 Asia Patient Scheduling Platform Revenue by Country
- 11.6.1 Asia Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Patient Scheduling Platform Revenue by Country (2021-2026)
- 11.6.3 Asia Patient Scheduling Platform Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Patient Scheduling Platform Revenue (2021-2032)
- 12.2 SAMEA Patient Scheduling Platform Revenue by Type (2021-2032)
- 12.2.1 SAMEA Patient Scheduling Platform Revenue by Type (2021-2026)
- 12.2.2 SAMEA Patient Scheduling Platform Revenue by Type (2027-2032)
- 12.3 SAMEA Patient Scheduling Platform Revenue Share by Type (2021-2032)
- 12.4 SAMEA Patient Scheduling Platform Revenue by Application (2021-2032)
- 12.4.1 SAMEA Patient Scheduling Platform Revenue by Application (2021-2026)
- 12.4.2 SAMEA Patient Scheduling Platform Revenue by Application (2027-2032)
- 12.5 SAMEA Patient Scheduling Platform Revenue Share by Application (2021-2032)
- 12.6 SAMEA Patient Scheduling Platform Revenue by Country
- 12.6.1 SAMEA Patient Scheduling Platform Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Patient Scheduling Platform Revenue by Country (2021-2026)
- 12.6.3 SAMEA Patient Scheduling Platform Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst